Author

Karin M. de Winter‐de Groot

Utrecht UniversityORCID 0000-0003-0666-3983Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Approach:experimental assay· 2 Organism:human· 2 Assay:ATAC-seq· 1 Research Focus:cell type annotation· 1 Assay:CITE-seq· 1 Assay:scRNA-seq· 1

Frequent Co-Authors

Cornelis Korstiaan van der EntiD· 2 shared Georgia N. Ithakisiou· 2 shared Jeffrey Matthijn BeekmaniD· 2 shared Annelotte M. VonkiD· 1 shared Antoni R. BlaazeriD· 1 shared Aranka Gerritsen· 1 shared Bahar Yetkin-ArikiD· 1 shared Bram M. BoschiD· 1 shared

Activity by Year

2023-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 35 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCell Biology

Cornelis Korstiaan van der EntORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Personalized multi-assay profiling of respiratory motile ciliopathies and mRNA therapy

Georgia N. Ithakisiou, Pim Cleijpool, Henriette H. M. Raeven, Bram M. Bosch, Wessel Hornman, Daniëlle Hoenselaar, Marinos Tziouvelis, Aranka Gerritsen, Matthew B. Smith, Loes A. Oosterhoff, R.B. Bhattacharjee, Zechen Wang, T. Noelle Lombana, Brandon A. Wustman, Cornelis Korstiaan van der Ent, , Bahar Yetkin-Arik

This study develops a personalized multi-assay platform using nasal epithelial cells to assess ciliary function and therapeutic response in primary ciliary dyskinesia.

bioRxiv · May 23, 2026 · PreprintCell Biology

FDA-Approved Drug Screening in Patient-Derived Organoids Demonstrates Potential of Drug Repurposing for Rare Cystic Fibrosis Genotypes

Eyleen de Poel, Sacha Spelier, Marne C. Hagemeijer, Peter van Mourik, Sylvia W.F. Suen, Annelotte M. Vonk, Jesse E. Brunsveld, Georgia N. Ithakisiou, Evelien Kruisselbrink, Hugo Oppelaar, Gitte Berkers, Karin M. de Winter‐de Groot, Sabine Heida-Michel, S.R. Jans, H. van Panhuis, , Jeffrey Matthijn Beekman

The paper screens 1400 FDA-approved drugs in CF patient-derived intestinal organoids using a functional assay to identify potential repurposing for rare CF genotypes.

Journal of Cystic Fibrosis · May 1, 2023Peer-reviewedMolecular Biology